Children with CKD have a significant burden, including fatigue and sleep disturbances.

Published Date: 13 Mar 2023

A new study by Sandra Amaral and her team has found that children with chronic kidney disease (CKD), regardless of disease severity,...

Read Full News

Latest News

Would Earlier Initiation of Clozapine Improve FEP Outcomes?

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Hidden Bacteria Found in Common Kidney Stones

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Showing Future Heart Risks Visually Helps Patients Manage BP

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Cardiometabolic Control Elusive in Adults With Hypertension

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

Low eGFR Not Associated With DKA Risk in T1D

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Super-Resolution Ultrasound Can Track Early Kidney Disease

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Todays Updates

Where Does Mistletoe Extract Fit in Supportive Cancer Care?

Mistletoe therapy may improve the QOL of patients with cancer; however, evidence does not support a survival benefit, limiting its role in routine oncology care.

A Chemo-Free Option for Some Advanced Endometrial Cancers?

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

Latest News

Higher response rates with clozapine after a single treatment failure raise questions about current recommendations and whether it should be used earlier in first-episode psychosis.

Researchers identify live bacteria within calcium kidney stones, raising new questions about stone formation and suggesting new targets for prevention and treatment.

Adding a tool that shows patients their 5-year risk for heart disease, along with monthly emails, may help manage blood pressure and cholesterol in people with hypertension, a trial shows.

Despite new therapies, metabolic risk hasn’t improved in more than a decade.

A new study supports the use of kidney-protective medication for patients with type 1 diabetes.

Noninvasive ultrasound localization microscopy-based assessment of intrarenal microvasculature can reveal microvascular abnormalities at an early stage in individuals with polycystic kidney disease.

News All Time

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

Younger Adults Face Pronounced Racial, Ethnic Gaps in Kidney Therapy

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

New MERD Risk Score Predicts Mortality for Kidney Transplant Waitlist Patients

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

Gentamicin May Not Reduce Post Kidney Transplant Urinary Tract Infection Risk

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

FDA Extends Sparsentan (Filspari) sNDA Review for Focal Segmental Glomerulosclerosis

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Elevated BMI and Physical Inactivity Drive Rising Global Hypertension-CKD Burden

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

Malnutrition Reverses Obesity Survival Advantage in Hospitalized Patients With End Stage Kidney Disease

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

AI-Based ZEBRA Model May Improve Detection of Fabry Nephropathy on Kidney Biopsy

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Low Exercise Tolerance Before Kidney Transplant Signals Poor Muscle Recovery

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Diabetes, Anuria May Predict High Postvoid Residual After Kidney Transplantation

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Global CKD Burden Projected to Rise in Young Adults and Decline in Children by 2050

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Depression's Implied Bilateral Link With Chronic Kidney Disease Progression

Young Adults With Glomerular Disease May Require Distinct Care

Young Adults With Glomerular Disease May Require Distinct Care

Q4 2025 Recap: Nephrology News and Updates

Q4 2025 Recap: Nephrology News and Updates

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

Serum Creatinine Trajectories May Predict 28-Day Mortality in CKD

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

FDA Grants Priority Review Of Biologics License Application For Atacicept In IgA Nephropathy

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

KDIGO Releases New Guideline for Anemia in Chronic Kidney Disease

Recommended News For You

Oncology Drug Shortages Persist, but Continue to Evolve

Daily physical activity, even at light intensities, linked to lower cancer risk

Research identifies nearly 200 potential breast carcinogens in food packaging materials

Investigations may result in novel combination therapies for early-stage lung cancers.

FDA Approves New Bladder Cancer First-Line Standard of Care.

FDA approves rivanetin as the first-line treatment for lung cancer.

Insurance Claim Denials for Preventive Care More Common in At-Risk Patients

Recommended Articles For You

Unlocking the Potential of Immune Checkpoint Inhibitors: A Pioneering Case Series on the Role of Immunotherapy in Microsatellite-Instability-High Colorectal Cancer 

Lentigo Maligna Melanoma: Everything You Need To Know about This Skin Cancer 

The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v 

The benefits and risks of taking fludrocortisone for adrenal insufficiency  

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Advancing Health in Africa

2.

Doxorubicin-Trabectedin Strategy Boosts Survival in Challenging Sarcoma

3.

Cardiomyocytes are shielded from chemotherapy damage by mitochondrial proteins.

4.

Short Shrift in Cancer Funding; Bypassing Familiar for Distant; Testing for BRCA.

5.

AI Breath Test IDs Cancers; More Grief for Prior Auth; Imatinib Discoverer Resigns

1.

Understanding Fibrosarcoma: What You Need to Know 

2.

The Power of White Blood Cells: How They Help Keep Us Healthy

3.

Antibody-Drug Conjugates in Oncology: Breakthroughs, Clinical Updates, and Pipeline Innovation

4.

Pembrolizumab Plus Lenvatinib in EBV-Associated Advanced Intrahepatic Cholangiocarcinoma: Case Study

5.

Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VI

2.

Efficient Management of First line ALK-rearranged NSCLC - Part IV

3.

Navigating the Complexities of Ph Negative ALL - Part VI

4.

Navigating the Complexities of Ph Negative ALL - Part XIV

5.

Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VIII

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot